Gene Query: MCM10

Dataset Description Geneva Score
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 126.97
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 53.58
Gene expression analysis of dengue-infected cells 47.56
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 44.07
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 41.49
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 40.05
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 39.98
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 39.8
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 39.02
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 38.49
Effect of CHKA knockdown on C4-2 cell transcriptome 37.86
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 36.74
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 36.54
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 36.3
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 35.02
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 34.13
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 33.53
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 32.09
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 31.69
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 30.74
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 30.47
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 30.13
Transcription control by the ENL YEATS domain in acute leukemia 30.0
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 30.0
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 29.69
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 29.59
A549 cells and MSR-A549 cells 29.59
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 28.56
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 27.84
Genome wide expression change by RNF168 knocking down in MCF-7 cells 27.12
RNA-seq of resting and activated CD4+ T cells +-JQ1 26.12
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 25.52
LncRNA-GAS5 negative regulation of YAP-target genes expression 24.92
Genome-wide analysis of Dengue virus 2 infected cells 24.69
The regulartory role of ZCCHC24 in splicing machinery 24.3
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 24.01
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 23.93
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 23.93
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 23.9
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 23.73
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 23.3
RNA-seq differential expression studies: more sequence, or more replication? 23.0
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 22.87
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 22.59
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 22.45
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 22.15
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 22.15
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 22.08
Identification of global regulators of T-helper cell lineage specification 21.94
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 21.94
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 21.56
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 21.52
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 21.5
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 21.5
Hijacking of stress response machinery by oncogenes in acute leukaemia 21.26
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 21.26
FBXW7 modulates stress response by post-translational modification of HSF1 21.11
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 21.11
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 21.02
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 21.0
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 20.89
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 20.89
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 20.5
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 20.5
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 20.47
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 20.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 20.41
Downregulation of DDX5/DDX17 and REST 20.36
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 20.32
A Unique Epigenomic Landscape Defines Human Erythropoiesis 20.32
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 19.79
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 19.69
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 19.52
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 19.35
HBEC-shp53-PCHD7 18.93
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 18.88
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 18.88
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 18.75
Role for citron kinase in prostate cancer growth 18.68
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 18.46
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  18.43
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 18.39
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 18.39
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 18.33
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 18.09
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 18.06
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 18.0
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 17.96
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 17.96
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 17.67
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 17.67
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 17.6
The landscape of alternative splicing in aggressive prostate cancers 17.47
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 17.45
RNA-seq analysis of uveal melanoma cells treated with FR900359 17.39
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 17.38
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 17.28
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 17.28
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 17.23
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 17.07
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 16.94
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 16.89
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 16.86
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 16.86
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 16.85
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 16.75
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 16.64
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 16.6
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 16.4
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 16.33
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 16.23
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 16.23
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 16.21
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 16.19
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 16.18
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 16.16
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 15.71
Global gene expression profile of dasatinib-resistant RCH-ACV cells 15.66
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 15.6
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 15.59
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 15.48
Integrin signaling regulates YAP/TAZ to control skin homeostasis 15.38
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 15.38
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 15.32
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 15.3
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 15.3
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 15.25
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 15.06
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 15.06
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 15.01
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 14.84
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 14.71
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 14.7
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 14.68
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 14.66
Studying the selectivity of a small molecule Synucleozid on transcriptome 14.66
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 14.61
TAF1 is critical for AE driven leukemogenesis 14.61
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 14.53
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 14.41
Transcriptome analysis of BAP1 knockout and restoration 14.41
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 14.24
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 14.24
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 14.18
Genome wide miR-191 target profile determined by RIP and gene expression profiling 14.18
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 14.11
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 14.09
Genes significantly down or Up-regulated upon RNF219 knockdown 14.07
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 14.06
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 14.05
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 14.03
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 14.03
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 14.0
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 13.99
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 13.94
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 13.94
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 13.84
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 13.63
Identification of Sin3B regulated genes during quiescence 13.6
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 13.48
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 13.48
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 13.43
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 13.43
Identification of HOXB13 target genes responsive to BET inhibitors 13.39
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 13.34
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 13.3
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 13.24
Transcriptomic analyssis following EHMT1/2 inhibition 13.22
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 13.21
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 13.19
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 13.19
Spliceosomal disruption of the non-canonical BAF complex in cancer 13.15
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 12.75
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 12.71
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 12.67
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 12.67
Targeting MTHFD2 in Acute Myeloid Leukemia 12.39
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 12.26
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 12.12
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 12.11
RNA transcriptome analysis during HSV-1 infection 12.09
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 11.95
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 11.88
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 11.84
NR2F2 study 11.81
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 11.81
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 11.8
Transcriptome analysis of U87 cells upon LINC00152 knockdown 11.8
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 11.76
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 11.76
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 11.65
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 11.65
N6-methyladenine DNA Modification in Glioblastoma 11.65
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 11.65
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 11.51
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 11.49
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 11.42
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 11.38
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 11.38
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 11.35
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 11.35
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 11.35
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 11.33
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 11.33
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 11.32
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 11.32
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 11.17
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 11.13
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 11.12
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 11.11
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 11.03
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 11.02
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 10.98
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 10.97
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 10.95
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 10.93
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 10.9
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 10.9
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 10.87
Gene induction by the USP6 oncogene in response to interferon 10.86
Transcriptome-wide identification of CELF2 functional targets in T cells 10.83
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 10.79
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 10.76
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 10.76
MYCi361 regulates MYC target genes 10.67
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 10.64
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 10.59
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 10.59
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 10.57
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 10.52
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 10.52
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 10.51
Retinoic acid suppresses MYB in adenoid cystic carcinoma 10.49
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 10.49
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 10.46
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 10.45
TGF-β regulation of miRNA expression in pancreatic cancer 10.45
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 10.44
RNAseq Analysis in glioblastoma cells treated with Mepazine 10.43
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 10.41
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 10.41
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 10.39
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 10.38
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 10.35
Differential gene expression of human melanoma cells [RNA-seq] 10.25
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 10.25
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 10.24
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 10.23
Global analysis of alternative splicing regulated by RBM10 10.23
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 10.22
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 10.22
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 10.21
The cohesin release factor WAPL restricts chromatin loop extension. 10.21
Transcriptome analysis of H9 hESC derived cerebral organoids 10.13
hTERT promotes cell adhesion and migration independent of telomerase activity 10.13
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 10.13
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 10.12
Cerebellar differentiation in Ataxia-Telangiectasia 10.11
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 10.08
Conservative alteration of chromosomal expression pattern across human solid tumor types 10.07
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 10.04
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 10.04
Human embryonic stem cells in E8 and AKIT culture medium 10.04
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 10.03
RNAseq analysis of ESRP regulated splicing events in prostate cancer 9.91
U1 snRNP telescripting regulates size-function stratified human genome 9.87
3’ Uridylation Expands miRNA Target Repertoire 9.83
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 9.83
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 9.76
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 9.75
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.71
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.71
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 9.71
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 9.71
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 9.68
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 9.67
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 9.66
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 9.63
Hepatitis C virus functionally sequesters miR-122 9.62
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 9.62
RNA-seq analysis to identify the genes regulated by p53-SET interplay 9.56
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 9.56
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 9.55
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 9.49
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 9.49
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 9.48
Seletive inhibition of CDK9 in DLBCL cell lines 9.47
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 9.44
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.42
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 9.38
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 9.33
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 9.32
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 9.3
Peptidomimetic blockade of MYB in acute myeloid leukemia 9.19
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 9.19
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 9.08
Effect of FGF13 depletion on the H460 cell line 9.07
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 9.02
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 9.01
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 9.0
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 8.99
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 8.96
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 8.92
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 8.86
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 8.84
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 8.84
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 8.81
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 8.81
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 8.78
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 8.78
6mer seed toxicity in tumour suppressive microRNAs 8.76
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 8.7
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 8.69
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 8.66
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.63
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 8.61
RNA-seq of naive and primed ES cells (NHSM) 8.58
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 8.54
BCL11B 8.54
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 8.5
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 8.5
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 8.48
BACH2 in human plasma cell fate decision 8.48
Overexpression and knockdown experiment for circCSNK1G3 8.43
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 8.43
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 8.43
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 8.36
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 8.34
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 8.34
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 8.34
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 8.34
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 8.33
Global Mapping of Human RNA-RNA Interactions 8.3
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 8.29
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 8.26
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 8.25
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 8.24
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 8.19
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 8.17
The effect of Abl kinases on non-small cell carcinoma global transcriptome 8.06
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 8.05
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 8.05
FOXP2's impact on the primate transcriptome 7.91
BASP1 modifies the Tamoxifen response 7.9
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 7.86
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 7.84
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 7.82
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 7.69
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 7.67
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 7.63
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 7.57
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 7.56
IRF2 is a master regulator of human keratinocyte stem cell fate 7.56
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.52
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 7.49
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 7.41
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 7.41
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 7.4
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 7.4
Total RNA-seq in ALL-SIL upon TLX1 knockdown 7.37
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.32
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 7.31
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 7.31
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 7.31
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 7.3
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 7.27
Transcriptomic analysis of ERR alpha orphan nuclear receptor 7.26
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 7.24
Entrectinib Resistance in a Neuroblastoma Xenograft Model 7.22
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 7.2
Nucleoporin-mediated regulation of cell identity genes 7.17
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 7.14
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 7.12
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 7.12
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 7.12
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 7.07
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 7.02
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 7.0
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 6.9
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 6.85
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 6.8
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 6.68
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 6.65
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 6.65
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 6.63
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 6.58
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 6.56
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 6.56
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 6.52
RNA sequencing with KSHV infection and enrichment for circular RNAs 6.51
LIN28A Over-expression RNAseq 6.5
MCF10A H-Ras RNA-Seq 6.46
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 6.32
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 6.32
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 6.29
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 6.24
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 6.2
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 6.2
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 6.2
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 6.18
Ro60-knockout cells 6.17
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 6.01
Gene expression profile of multiple myeloma cell lines treated with CB-5083 5.99
Effect of from Human Umbilical Vein Endothelial Cells 5.72
Transcriptome profiling of 5 human adenocarcinoma cell lines 5.68
MCF-7 as a model for functional analysis of breast cancer risk variants 5.61
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 5.54
EWS-Fli and LNC regulated genes in comparison to GFP samples 5.42
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 5.23
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.21
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 5.14
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 5.14
HNRNPM-regulated splicing dependencies in prostate cancer 5.08
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 5.08
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 4.83
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 4.76
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.76
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.76
Effect of drugs on transcriptomic profiles 4.73
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.65
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 4.53
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.48
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 4.45
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 4.28
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.15
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.15
The cohesin complex prevents Myc-induced replication stress 4.13
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 4.07
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.8
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.66
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.66
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.62
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 3.61
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.42
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.41
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.3
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.3
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.24
p53 activity results in DNA replication fork processivity 3.17
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 3.12
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.88
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.81
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.75
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 2.71
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.7
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.61
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.57
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.54
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.5
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.5
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 2.44
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.44
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.34
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 2.29
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.28
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.24
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.24
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.24
6mer seed toxicity in viral microRNAs 2.1
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.06
Modulation of nonsense-mediated decay by rapamycin 2.04
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.01
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.0
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.73
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.68
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.56
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.55
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.55
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.39
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.36
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.36
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.35
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.09
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.01
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.01
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.83
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.78
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.78
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.78
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.74
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.7
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.58
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.56
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.54
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.51
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.47
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.45
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.37
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.35
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.35
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.26
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.13
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.12
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.07
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.07
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.07
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.06
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.03
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.03
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation